Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response
- 30 September 2007
- journal article
- case report
- Published by Elsevier BV in Tuberculosis
- Vol. 87 (5), 459-463
- https://doi.org/10.1016/j.tube.2007.05.013
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patientsEuropean Respiratory Journal, 2006
- 18F-Fluorodeoxyglucose Positron Emission Tomography Contributes to the Diagnosis and Management of Infections in Patients With Multiple Myeloma: A Study of 165 Infectious EpisodesJournal of Clinical Oncology, 2005
- Interferon-γ Assays for TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disordersSeminars in Nuclear Medicine, 2004
- Diagnosis of Deep Septic Thrombophlebitis in Cancer Patients by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Scanning: A Preliminary ReportJournal of Clinical Oncology, 2004
- Priorities for the Treatment of Latent Tuberculosis Infection in the United StatesNew England Journal of Medicine, 2004
- Abnormal FDG PET Imaging in Tuberculosis Appearing Like LymphomaClinical Nuclear Medicine, 2004
- Clinical Value of [18F]fluoro-Deoxyglucose Positron Emission Tomography for Patients with Fever of Unknown OriginClinical Infectious Diseases, 2001
- F-18-FDG Uptake in TuberculosisClinical Nuclear Medicine, 1998